QTTB Q32 Bio Inc.
Healthcare$7.09+22.24%ClosedMarket Cap: $90.6M
As of 2026-05-26
Valuation
P/E (TTM)
2.43
PEG
0.01
P/B
1.77
P/S
1.38
EV/EBITDA
1.55
DCF Value
$3.19
FCF Yield
-37.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.5%
Operating Margin
39.8%
Net Margin
61.9%
ROE
230.7%
ROA
52.2%
ROIC
36.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-7.7M | $-7.6M | $— | — |
| Q4 null | $53.7M | 99.8% | $45.9M | $57.7M | $— | — |
| FY null | $53.7M | 99.3% | $16.9M | $29.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.6M | $-7.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-9.2M | $-9.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-12.2M | $-11.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-14.5M | $-14.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-66.1M | $-47.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-18.8M | $-17.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-17.9M | $-17.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-14.8M | $1.0M | $— | — |
| Q4 2023 | $-14.7M | 100.0% | $-25.8M | $-27.1M | $-5.00 | — |